These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 2974027

  • 21. A bispecific recombinant immunotoxin, DT2219, targeting human CD19 and CD22 receptors in a mouse xenograft model of B-cell leukemia/lymphoma.
    Vallera DA, Todhunter DA, Kuroki DW, Shu Y, Sicheneder A, Chen H.
    Clin Cancer Res; 2005 May 15; 11(10):3879-88. PubMed ID: 15897589
    [Abstract] [Full Text] [Related]

  • 22. Improved cytotoxic activity toward cell lines and fresh leukemia cells of a mutant anti-CD22 immunotoxin obtained by antibody phage display.
    Salvatore G, Beers R, Margulies I, Kreitman RJ, Pastan I.
    Clin Cancer Res; 2002 Apr 15; 8(4):995-1002. PubMed ID: 11948105
    [Abstract] [Full Text] [Related]

  • 23. Diagnostic usefulness of aberrant CD22 expression in differentiating neoplastic cells of B-Cell chronic lymphoproliferative disorders from admixed benign B cells in four-color multiparameter flow cytometry.
    Huang J, Fan G, Zhong Y, Gatter K, Braziel R, Gross G, Bakke A.
    Am J Clin Pathol; 2005 Jun 15; 123(6):826-32. PubMed ID: 15899772
    [Abstract] [Full Text] [Related]

  • 24. [Analysis of cytoplasmic antigens in acute leukemia by flow cytometry].
    Kawai S, Zha Z, Yamamoto Y, Nakadate H, Kawakami K, Kikuta A, Utsumi J, Nishikawa K, Mimaya J, Miyake M.
    Rinsho Ketsueki; 1993 Jan 15; 34(1):13-20. PubMed ID: 8450602
    [Abstract] [Full Text] [Related]

  • 25. Membrane CD22 defines circulating myeloma-related cells as mature or later B cells.
    Perfetti V, Vignarelli MC, Bellotti V, Glennie MJ, Zorzoli I, Ubbiali P, Obici L, Massa M, Ippoliti G, Ascari E, Merlini G.
    Lab Invest; 1997 Oct 15; 77(4):333-44. PubMed ID: 9354768
    [Abstract] [Full Text] [Related]

  • 26. Differential control of CD22 ligand expression on B and T lymphocytes, and enhanced expression in murine systemic lupus.
    Lajaunias F, Ida A, Kikuchi S, Fossati-Jimack L, Martinez-Soria E, Moll T, Law CL, Izui S.
    Arthritis Rheum; 2003 Jun 15; 48(6):1612-21. PubMed ID: 12794829
    [Abstract] [Full Text] [Related]

  • 27. Increased incidence of EBV-associated lymphoproliferative disorders after allogeneic stem cell transplantation from matched unrelated donors due to a change of T cell depletion technique.
    Meijer E, Slaper-Cortenbach IC, Thijsen SF, Dekker AW, Verdonck LF.
    Bone Marrow Transplant; 2002 Feb 15; 29(4):335-9. PubMed ID: 11896431
    [Abstract] [Full Text] [Related]

  • 28. Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease.
    Babusíková O, Mesárosová A, Koníková M, Kusenda J, Glasová M, Klobusická M.
    Neoplasma; 1993 Feb 15; 40(5):275-81. PubMed ID: 8272155
    [Abstract] [Full Text] [Related]

  • 29. A comparison of some leucocyte differentiation markers and the adenosine deaminase and purine nucleoside phosphorylase values in B and T cell leukemias and lymphomas.
    Mesárosová A, Hrivnáková A, Babusíková O.
    Neoplasma; 1995 Feb 15; 42(6):307-12. PubMed ID: 8592572
    [Abstract] [Full Text] [Related]

  • 30. T cell receptor expression can switch on and off at a posttranslational level.
    Maecker HT, Jokinen DM, Fisher RI.
    J Immunol; 1992 Sep 01; 149(5):1619-25. PubMed ID: 1387145
    [Abstract] [Full Text] [Related]

  • 31. Differential expression of the B cell-restricted molecule CD22 on neonatal B lymphocytes depending upon antigen stimulation.
    Viemann D, Schlenke P, Hammers HJ, Kirchner H, Kruse A.
    Eur J Immunol; 2000 Feb 01; 30(2):550-9. PubMed ID: 10671211
    [Abstract] [Full Text] [Related]

  • 32. Monoclonal antibody studies in B(non-T)-cell malignancies.
    Shimoyama M, Minato K, Tobinai K, Nagai M, Hirose M.
    Jpn J Clin Oncol; 1983 Sep 01; 13(3):477-88. PubMed ID: 6417373
    [Abstract] [Full Text] [Related]

  • 33. Quantitative immunocytofluorometry--new parameters for the definition of leukemia cells.
    Babusíková O, Glasová M, Stasáková J, Kusenda J, Koníková E.
    Neoplasma; 1997 Sep 01; 44(6):348-55. PubMed ID: 9605006
    [Abstract] [Full Text] [Related]

  • 34. Evaluation of different fixation-permeabilization methods for simultaneous detection of surface, cytoplasmic markers and DNA analysis by flow cytometry in some human hematopoietic cell lines.
    Glasová M, Koníková E, Kusenda J, Babusíková O.
    Neoplasma; 1995 Sep 01; 42(6):337-46. PubMed ID: 8592577
    [Abstract] [Full Text] [Related]

  • 35. Constitutive endocytosis and degradation of CD22 by human B cells.
    Shan D, Press OW.
    J Immunol; 1995 May 01; 154(9):4466-75. PubMed ID: 7722303
    [Abstract] [Full Text] [Related]

  • 36. B cell antigen receptor-mediated apoptosis. Importance of accessory molecules CD19 and CD22, and of surface IgM cross-linking.
    Chaouchi N, Vazquez A, Galanaud P, Leprince C.
    J Immunol; 1995 Apr 01; 154(7):3096-104. PubMed ID: 7534787
    [Abstract] [Full Text] [Related]

  • 37. Delivery of saporin to human B-cell lymphoma using bispecific antibody: targeting via CD22 but not CD19, CD37, or immunoglobulin results in efficient killing.
    Bonardi MA, French RR, Amlot P, Gromo G, Modena D, Glennie MJ.
    Cancer Res; 1993 Jul 01; 53(13):3015-21. PubMed ID: 7686448
    [Abstract] [Full Text] [Related]

  • 38. Detection of cytoplasmic and surface membrane markers in cells of some human hematopoietic cell lines.
    Koníková E, Babusíková O, Kusenda J, Glasová M.
    Neoplasma; 1992 Jul 01; 39(6):337-42. PubMed ID: 1491722
    [Abstract] [Full Text] [Related]

  • 39. CD3-negative, CD20-positive T-cell prolymphocytic leukemia: case report and review of the literature.
    Tamayose K, Sato N, Ando J, Sugimoto K, Oshimi K.
    Am J Hematol; 2002 Dec 01; 71(4):331-5. PubMed ID: 12447967
    [Abstract] [Full Text] [Related]

  • 40. Ig domains 1 and 2 of murine CD22 constitute the ligand-binding domain and bind multiple sialylated ligands expressed on B and T cells.
    Law CL, Aruffo A, Chandran KA, Doty RT, Clark EA.
    J Immunol; 1995 Oct 01; 155(7):3368-76. PubMed ID: 7561031
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.